1. From Clinical Pharmacology and Ophthalmology, Pfizer Global Research and Development, and
2. the Charles River Laboratories, Preclinical Services, Montreal, Quebec, Canada; and
3. CovX Research, Biotherapeutics Research Division of Pfizer, San Diego, California.
4. Pharmatherapeutics Research, Pfizer Inc., San Diego, California;